Fundraising FoxRedx Pharma
5 known investors
Find your way into Redx Pharma
Sign up to see every warm intro you have to Redx Pharma
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Redx Pharma team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Redx is a clinical-stage biotechnology company developing small molecule targeted medicines focused on fibrotic diseases, leveraging ROCK pathway inhibitors and novel targets. The company also maintains an oncology pipeline with partnered and in-house programs for unmet medical needs.
Founders & leadership
LA
Lisa AnsonChief Executive Officer
Board
BC
Bernard CoulieIndependent Director
Investors · 5
Abingworth✓ confirmed by Redx PharmaLondon · $15M – $30M
How we know: the company's own site · open dataset · 5k.vc investor directory · Not right? Tell us
REDMILE✓ confirmed by Redx PharmaSan Francisco
How we know: the company's own site · Not right? Tell us
Companies House · registry record
View on Companies House ↗Insolvency history
- Registered name
- REDX PHARMA LIMITED
- Company number
- 07368089
- Status
- Active
- Company type
- Private limited company
- Incorporated
- 7 Sept 2010
- Registered office
- Block 33 Mereside, Alderley Park, Macclesfield, SK10 4TG
- Nature of business (SIC)
- 72110 — Research and experimental development on biotechnology
- Previous names
- REDX PHARMA PLC (2015–2024)REDX PHARMA LIMITED (2010–2015)
- Accounts
- last made up to 30 Sept 2024 · next due 30 Sept 2026
- Confirmation statement
- last made up to 7 Sept 2025 · next due 21 Sept 2026
Current officers · 7
- Andrew William Booth — secretary, appointed 1 Oct 2025
- Lisa Mary Whewell Anson — director, appointed 1 Jun 2018
- Natalie Berner — director, appointed 18 May 2021
- Claire Catherinet — director, appointed 10 May 2024
- Jeremy Charles Green — director, appointed 1 Jan 2025
- Bernhard Jurgen Kirschbaum — director, appointed 1 Jan 2016
- Peter Eric Presland — director, appointed 3 Nov 2017
Source: Companies House public register · retrieved 16 Aug 2026. Contains public sector information licensed under the Open Government Licence v3.0.
Frequently asked questions
- What does Redx Pharma do?
- Redx is a clinical-stage biotechnology company developing small molecule targeted medicines focused on fibrotic diseases, leveraging ROCK pathway inhibitors and novel targets. The company also maintains an oncology pipeline with partnered and in-house programs for unmet medical needs.
- Who are Redx Pharma's investors?
- Redx Pharma's investors include Abingworth, REDMILE, 5AM Ventures, Perscitus LLP, Sofinnova Partners.